Ascendis Pharma A/S (A1SN34 SA) stock market data APIs
R$63.149
0(0%)
as of July 4, 2025
Try our APIs with
free plan!
Ascendis Pharma A/S Financial Data Overview
Price chart is built with
Anychart
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.
Prev. Close
63.149
Open
63.149
High
63.149
Low
63.149
52 wk Range
42.84-67.6
Market Cap
57 209 M
Shares Outstanding
60 494 K
Revenue
369 M
Beta
0.361
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Ascendis Pharma A/S data using free add-ons & libraries
Get Ascendis Pharma A/S Fundamental Data
Ascendis Pharma A/S Fundamental data includes:
- Net Revenue: 369 M
- EBITDA: -328 827 008
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Ascendis Pharma A/S News
New
High Growth Tech Stocks In The US To Watch This July 2025
The United States market has experienced a 2.1% increase over the past week and is up 14% over the last year, with earnings projected to grow by 15% annually. In this environment, identifying high gro...
Exploring 3 High Growth Tech Stocks in the US Market
Over the last 7 days, the United States market has risen by 2.1% and over the past 12 months, it is up by 14%, with earnings expected to grow by 15% per annum in the coming years. In this favorable en...
High Growth Tech Stocks In The US Market With Promising Potential
The U.S. stock market has recently experienced a surge, with the S&P 500 and Nasdaq Composite reaching new all-time highs following a robust June jobs report that exceeded expectations and fueled opti...
High Growth Tech Stocks In The US Market July 2025
Over the last 7 days, the United States market has risen by 2.2% and is up 13% over the last 12 months, with earnings forecasted to grow by 15% annually. In this favorable environment, identifying hig...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
